Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, November 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 49 articles: HTML format

Single Articles

1. XING Y, Liu C, Zhang C, Zhou D, et al
   Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension.
   Respir Res. 2025;26:303.
   PubMed    
   Abstract available
   
   

2. WHITE RD, Demirer M, Sebro RA, Cortopassi IO, et al
   Artificial intelligence improves detection and classification of pulmonary venous hypertension related to left ventricular diastolic dysfunction by chest radiography.
   Sci Rep. 2025;15:38181.
   PubMed    
   Abstract available
   
   

3. BOUCLY A, Beauvais A, Lacoste-Palasset T, Jevnikar M, et al
   Evolving paradigms in pulmonary hypertension: Highlights of the 6(th) French Pulmonary Hypertension Network Meeting.
   Respir Med Res. 2025;88:101215.
   PubMed    
   
   
   

4. MOON GS, Scheel PJ 3rd, Montovano M, Kaushik M, et al
   A Novel Computational Pipeline for Acquiring Pressure-Volume Hemodynamics of the Right Ventricle in Pulmonary Hypertension.
   JACC Heart Fail. 2025 Oct 31:102753. doi: 10.1016/j.jchf.2025.102753.
   PubMed    
   Abstract available
   
   

5. ALTURAIF N, Lin E, Sundararaghavan A, Mercurio V, et al
   Predicting outcomes in patients with pulmonary hypertension using right ventricular global longitudinal strain versus tricuspid annular plane systolic excursion (TAPSE) and fractional area change: a retrospective analysis.
   J Cardiovasc Imaging. 2025;33:15.
   PubMed    
   Abstract available
   
   

6. YANG Y, Yu H, Xiang Q, Wu J, et al
   Assessment of a Grad-CAM interpretable deep learning model for HAPE diagnosis: performance and pitfalls in severity stratification from chest radiographs.
   BMC Med Inform Decis Mak. 2025;25:402.
   PubMed    
   Abstract available
   
   

7. LIU H, Lu JW, Wu CH, Ho YJ, et al
   Dynamic Immunomodulation by Hydrogen Capsule Therapy in SLE-associated Pulmonary Arterial Hypertension: A Case Report.
   In Vivo. 2025;39:3656-3664.
   PubMed    
   Abstract available
   
   

8. LIU A, Wang H, Xi L, Du J, et al
   Causal Effect of Pulmonary Hypertension on Brain Structure: A Mendelian Randomization Study Combined With Brain Magnetic Resonance Imaging.
   Cureus. 2025;17:e95493.
   PubMed    
   Abstract available
   
   

9. GUENTHER A, Tello S, Schoppe MC, Pons-Kuehnemann J, et al
   Pulmonary Hypertension Drives Prognosis in Idiopathic Pulmonary Fibrosis: Insights from the European IPF Registry.
   J Clin Med. 2025;14:7352.
   PubMed    
   Abstract available
   
   

10. CHOJNACKA K, Singh Y, Gahlaut S, Blaz W, et al
    Persistent Pulmonary Hypertension of the Newborn: A Pragmatic Review of Pathophysiology, Diagnosis, and Advances in Management.
    Biomedicines. 2025;13:2332.
    PubMed    
    Abstract available
    
    

11. XIAODONG Z, Min W, Jinsong H, Yuemei L, et al
    Prolonged intra-aortic balloon pump support successfully reversed severe pulmonary hypertension prior to heart transplantation.
    J Cardiothorac Surg. 2025;20:402.
    PubMed    
    Abstract available
    
    

12. JAIN S, Kaur A, Qadeer A, Ghosh V, et al
    Leveraging Artificial Intelligence for the Diagnosis of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Opportunities, Challenges, and Future Perspectives.
    Adv Respir Med. 2025;93:47.
    PubMed    
    Abstract available
    
    

13. FISCUS G, Dagher C, O'Sullivan D, Carollo B, et al
    Development of a Tool to Assess the Severity of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Guide to Assist Therapeutic Choices.
    Adv Respir Med. 2025;93:41.
    PubMed    
    Abstract available
    
    

14. GUAN Y, Wen X, Zhang X, Xu Z, et al
    Novel Pulmonary Manifestations in Pediatric Late-Onset Congenital Central Hypoventilation Syndrome: A Case Series of PHOX2B-Associated Pulmonary Hypertension and Pulmonary Alveolar Hemorrhage.
    Pediatr Pulmonol. 2025;60:e71347.
    PubMed    
    
    
    

15. KEMPTON H, Olsen N, Kearney K, Hayward CS, et al
    Empiric Pulmonary Arterial Compliance Reflects the Resistance-Compliance Relationship and Predicts Mortality in Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70184.
    PubMed    
    Abstract available
    
    

16. LU J, Zinzuwadia A, Sullivan J, Perez-Lopez P, et al
    Echocardiographic Evaluation of Pulmonary Hypertension: A Contemporary Review of the American Society of Echocardiography (ASE) Guidelines and Emerging Modalities.
    Curr Cardiol Rep. 2025;27:154.
    PubMed    
    Abstract available
    
    

17. MANZI G, Badagliacca R, D'Alto M, Ghio S, et al
    [Survey on pulmonary arterial hypertension: a picture of the Italian reality].
    G Ital Cardiol (Rome). 2025;26:833-839.
    PubMed    
    Abstract available
    
    

18. KAMIGAICHI A, Tsutani Y, Tsuchiya A, Utsunomiya H, et al
    Lobectomy Induces Exercise-Induced Pulmonary Hypertension and Effort Intolerance Compared With Sublobar Resection.
    JTO Clin Res Rep. 2025;6:100903.
    PubMed    
    Abstract available
    
    

19. MWIZERWA L, Joye R, Cousin VL, Malaspinas I, et al
    Two case reports of idiopathic prenatal closure of the ductus arteriosus complicated at birth by severe pulmonary hypertension successfully treated without intubation.
    Transl Pediatr. 2025;14:2374-2380.
    PubMed    
    Abstract available
    
    

20. KOSANOVIC D
    High Altitude-Induced Pulmonary Hypertension: Our Scientific Journey to Prove Cold Exposure Is Also an Important Cause.
    Pulm Circ. 2025;15:e70186.
    PubMed    
    
    
    

21. ANNALISA C, Gianmarco S
    Reply To: "Pulmonary Artery Dilatation in Different Causes of Pulmonary Hypertension".
    Pulm Circ. 2025;15:e70175.
    PubMed    
    
    
    

22. BUTROUS G
    Early Development of Sildenafil for Pulmonary Hypertension: A Retrospective Account.
    Pulm Circ. 2025;15:e70188.
    PubMed    
    
    
    

23. CHERNYAEV AL
    Northern Pulmonary Hypertension: Personal Experience and Brief History.
    Pulm Circ. 2025;15:e70190.
    PubMed    
    
    
    

24. KAMENY R, Van Wormer S, Varghese NP
    A Joint Perspective on End-of-Life Care in Pediatric Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70181.
    PubMed    
    
    
    

25. ZHENG W, Li T, Wei J, Yan Y, et al
    Retraction to: Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression.
    Korean J Physiol Pharmacol. 2025;29:779.
    PubMed    
    
    
    

26. WAKISAKA Y, Inai K, Harada G, Asagai S, et al
    Persistence of pulmonary hypertension in patients with ventricular septal defect after intracardiac repair: insights from a long-term follow-up study.
    Cardiol Young. 2025 Oct 27:1-5. doi: 10.1017/S1047951125110159.
    PubMed    
    Abstract available
    
    

27. ZHOU Y, Xu L, Ou A, Gan S, et al
    Identification of potential core genes in idiopathic pulmonary arterial hypertension: An observational study highlighting the role of VEGFA.
    Medicine (Baltimore). 2025;104:e45398.
    PubMed    
    Abstract available
    
    

28. LEHTINEN ML, Ropponen J, Kesavuori R, Wilkman E, et al
    Bridging to a delayed pulmonary endarterectomy in massive acute-on-chronic pulmonary thromboembolism: a case report.
    J Cardiothorac Surg. 2025;20:391.
    PubMed    
    Abstract available
    
    

29. WATSON H, Patel B, Caccamo M
    Pulmonary Hypertension in Left Heart Disease and Chronic Right Ventricular Failure.
    Med Clin North Am. 2025;109:1345-1364.
    PubMed    
    Abstract available
    
    

30. DENG X, Liu Y, Liang Y, Hu C, et al
    The HIF1alpha-PUM1-KCNK3 axis drives pulmonary hypertension by destabilizing KCNK3 mRNA in pulmonary artery smooth muscle cells.
    Biochim Biophys Acta Mol Basis Dis. 2025;1872:168092.
    PubMed    
    Abstract available
    
    

31. MCKENNA AM, Pradhan NM, Farber HW, Hon SM, et al
    Management of Pulmonary Hypertension in Pregnancy.
    Curr Heart Fail Rep. 2025;22:30.
    PubMed    
    Abstract available
    
    

32. PROHASKA CC, Yaqoob M, Reddy R, Samant M, et al
    Evaluation and Management of Sepsis in Pulmonary Hypertension.
    J Intensive Care Med. 2025 Oct 23:8850666251388409.
    PubMed    
    Abstract available
    
    

33. HU S, Tan JS, Zhu S, Hua L, et al
    Polygenic risk score and clinical factors predict incident idiopathic pulmonary arterial hypertension.
    Respir Med. 2025;248:108404.
    PubMed    
    Abstract available
    
    

34. LIU Z, Fu Q, Shao Y, Cao J, et al
    Triangulation evidence for the causal effect of monocytes on pulmonary artery hypertension: a Mendelian randomization study and results from NHANES.
    Respir Med. 2025;248:108388.
    PubMed    
    Abstract available
    
    

35. REN Y, Gan C
    Atypical presentation of ALCAPA in a young boy: a case report.
    Cardiol Young. 2025;35:2187-2189.
    PubMed    
    Abstract available
    
    

36. YU W, Liu M, Qin W, Liu J, et al
    Artificial Intelligence Chest CT Imaging for the Diagnosis of Tuberculosis-Destroyed Lung with PH.
    Respir Med. 2025 Sep 24:108377. doi: 10.1016/j.rmed.2025.108377.
    PubMed    
    Abstract available
    
    

37. MERC P, Demi?r R, Zeren M, Si?nan UY, et al
    Effects of kettlebell exercise training on functional capacity and metabolic costs of activities of daily living in patients with pulmonary arterial hypertension: A randomized controlled trial.
    Respir Med. 2025;248:108371.
    PubMed    
    Abstract available
    
    

38. LEI C, Su S, Yang Z, Huayu M, et al
    Pharmacodynamic substances and molecular mechanisms of Tsantan Sumtang alleviating hypoxic pulmonary vascular remodeling.
    J Ethnopharmacol. 2026;355.
    PubMed    
    Abstract available
    
    

39. FRAZZETTO F, Piccinelli E, Pilati M, Rebonato M, et al
    Use of atrial flow regulator device in children and patients with CHD: a literature review.
    Cardiol Young. 2025;35:1975-1981.
    PubMed    
    Abstract available
    
    

40. SAHAY S, Palevsky H, El-Kersh K, Restrepo-Jaramillo R, et al
    BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
    Respir Med. 2025;248:108318.
    PubMed    
    Abstract available
    
    

41. COBER ND, McCourt E, Godoy RS, Deng Y, et al
    Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension.
    Cardiovasc Res. 2025;121:2095-2112.
    PubMed    
    Abstract available
    
    

42. SUCHANEK V, Jakubicek R, Hrdlicka J, Novak M, et al
    Fully automated Bayesian analysis for quantifying the extent and distribution of pulmonary perfusion changes on CT pulmonary angiography in CTEPH.
    Eur Radiol. 2025;35:6996-7003.
    PubMed    
    Abstract available
    
    

43. JING S, Qian J, Ying H, Mao P, et al
    Activin A-Activated ALK4 Induces Pathogenic Th17-Involved Endothelial-Mesenchymal Transition in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Arthritis Rheumatol. 2025;77:1533-1547.
    PubMed    
    Abstract available
    
    

44. KUMARI J, Advani M, Purohit G
    Correlation of spirometry findings and post-six-minute walk test oxygen desaturation in chronic simple silicosis patients with age, duration of silica exposure, smoking pack years, occupation and mean pulmonary artery pressure.
    Monaldi Arch Chest Dis. 2025;95.
    PubMed    
    Abstract available
    
    

45. KOHLI A, DuBrock HM, Boland JM, Kennedy CC, et al
    A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202505-1140.
    PubMed    
    
    
    

46. SAVALE L, d'Humieres T, Boucly A, Habibi A, et al
    Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.
    Am J Respir Crit Care Med. 2025;211:2096-2104.
    PubMed    
    Abstract available
    
    

47. ABREU P, Moon R, Mendelson JB, Markowski T, et al
    Proteomic and metabolomic profiling nominates druggable targets and biomarkers for pulmonary arterial hypertension-associated myopathy and exercise intolerance in male monocrotaline rats.
    J Heart Lung Transplant. 2025;44:1798-1808.
    PubMed    
    Abstract available
    
    

48. HJALMARSSON C, Thakur T, Weiss T, Bjorklund E, et al
    Risk assessment models and survival in pulmonary arterial hypertension: A SPAHR analysis.
    J Heart Lung Transplant. 2025;44:1787-1797.
    PubMed    
    Abstract available
    
    

49. BERGOT E, Fertin M, Dewavrin MG, Prevot G, et al
    Start up: A French program to support patients with pulmonary arterial hypertension during the adjustment of prostanoids to the individualized optimal dose.
    PLoS One. 2025;20:e0331008.
    PubMed    
    Abstract available